PreciousGPT
AI models for digital -omics experiments and drug discovery.
Executive Summary
PreciousGPT is Insilico Medicine's proprietary series of AI models designed to enable digital -omics experiments. These models are built by training large language models on extensive omics-level data, allowing for advanced analysis and insights in biological research. The platform aims to transform drug discovery and development by providing a powerful tool for understanding complex biological systems. The PreciousGPT series has been recognized in scientific literature, with its models featured in peer-reviewed papers in the journal Aging. This highlights its application in exploring critical biological processes and contributing to scientific understanding, particularly in areas like aging research.
Use Cases
- Enabling digital -omics experiments for biological research.
- Training large language models on omics-level data.
- Exploring biological processes and disease mechanisms, such as aging.
- Accelerating drug discovery and development workflows.
Features
Intelligence
- Digital Omics Experiments: Enables the execution of advanced digital experiments using comprehensive omics-level data.
- Omics-level LLM Training: Leverages large language models trained on vast biological omics datasets for deep analysis.
- Biological Process Exploration: Applied in research to explore complex biological processes and disease mechanisms, such as aging.
Technical Specifications
- Architecture
- Generative AI, Large Language Models
AI/ML Stack
- Large Language Models (LLMs)
- Generative AI
Pricing
- Target Customer
- Pharmaceutical companies,Biotechnology firms,Academic research institutions
About Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company that leverages artificial intelligence and deep learning to accelerate drug discovery and development. The company focuses on therapeutic solutions for cancer, fibrosis, immunity, central nervous system diseases, and age-related conditions, utilizing its proprietary Pharma.AI platform to discover novel targets, design new molecules, and advance candidates into human clinical trials.